Timing of Gene Therapy Interventions: The Earlier, the Better.
作者信息
Gray Steven J
机构信息
Gene Therapy Center and Department of Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
出版信息
Mol Ther. 2016 Jun;24(6):1017-1018. doi: 10.1038/mt.2016.20.
Abstract
摘要
相似文献
1
Timing of Gene Therapy Interventions: The Earlier, the Better.基因治疗干预的时机：越早越好。
Mol Ther. 2016 Jun;24(6):1017-1018. doi: 10.1038/mt.2016.20.
2
Stroke rehabilitation patients, practice, and outcomes: is earlier and more aggressive therapy better?中风康复患者、实践与结局：更早且更积极的治疗是否更佳？
Arch Phys Med Rehabil. 2005 Dec;86(12 Suppl 2):S101-S114. doi: 10.1016/j.apmr.2005.09.016.
3
Timing of restorative proctocolectomy in patients with medically refractory ulcerative colitis: the patient's point of view.在药物难治性溃疡性结肠炎患者中择期行直肠结肠切除术的时机：患者的观点。
Dis Colon Rectum. 2012 Jul;55(7):756-61. doi: 10.1097/DCR.0b013e318251e004.
4
Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.
Arch Intern Med. 2004 Jun 14;164(11):1206-12. doi: 10.1001/archinte.164.11.1206.
5
Difference in peak weight transfer and timing based on golf handicap.基于差点的峰值体重转移和时间差异。
J Strength Cond Res. 2013 Sep;27(9):2481-6. doi: 10.1519/JSC.0b013e31827f4da6.
6
Trapezius muscle timing during selected shoulder rehabilitation exercises.特定肩部康复锻炼过程中斜方肌的运动时机
J Orthop Sports Phys Ther. 2009 Oct;39(10):743-52. doi: 10.2519/jospt.2009.3089.
7
Timing of continuous renal replacement therapy and mortality in critically ill children*.危重症儿童连续性肾脏替代治疗时机与死亡率的关系*。
Crit Care Med. 2014 Apr;42(4):943-53. doi: 10.1097/CCM.0000000000000039.
8
Transitions in body and behavior: a meta-analytic study on the relationship between pubertal development and adolescent sexual behavior.身体与行为的转变：关于青春期发育与青少年性行为之间关系的一项元分析研究
J Adolesc Health. 2015 Jun;56(6):586-98. doi: 10.1016/j.jadohealth.2014.11.019. Epub 2015 Jan 27.
9
Optimal timing of speech and language therapy for aphasia after stroke: more evidence needed.中风后失语症言语和语言治疗的最佳时机：仍需更多证据。
Expert Rev Neurother. 2015;15(8):885-93. doi: 10.1586/14737175.2015.1058161. Epub 2015 Jun 18.
10
Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy.根据心电图估算的缺血发作时间在预测急性前壁心肌梗死再灌注治疗后的预后方面优于既往时间：丹麦急性心肌梗死试验2（DANAMI-2）子研究。
Am Heart J. 2007 Jul;154(1):61.e1-8. doi: 10.1016/j.ahj.2007.04.003.
引用本文的文献
1
Gene therapy of rare diseases as a milestone in medicine - overview of the field and report on initial experiences in Slovenia.罕见病的基因治疗作为医学上的一个里程碑——该领域概述及斯洛文尼亚的初步经验报告
Orphanet J Rare Dis. 2025 Jun 5;20(1):279. doi: 10.1186/s13023-025-03828-8.
2
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.线粒体疾病：从分子机制到治疗进展
Signal Transduct Target Ther. 2025 Jan 10;10(1):9. doi: 10.1038/s41392-024-02044-3.
3
Making sense of missense: challenges and opportunities in variant pathogenicity prediction.理解错义突变：变异致病性预测中的挑战与机遇
Dis Model Mech. 2024 Dec 1;17(12). doi: 10.1242/dmm.052218. Epub 2024 Dec 16.
4
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.遗传性痉挛性截瘫 47 型 AP4B1 基因替代治疗的临床前开发。
EMBO Mol Med. 2024 Nov;16(11):2882-2917. doi: 10.1038/s44321-024-00148-5. Epub 2024 Oct 2.
5
Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants.深度突变扫描揭示了数千种天冬氨酸酶变体的降解与毒性之间的相关性。
Nat Commun. 2024 May 13;15(1):4026. doi: 10.1038/s41467-024-48481-0.
6
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.天冬氨酸酰基转移酶的细胞和分子机制及其在卡纳万病中的作用。
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
7
Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis.腺相关病毒血清型 9 介导的基因治疗对 AB 变异型 GM2 神经节苷脂贮积症的疗效。
Int J Mol Sci. 2023 Sep 27;24(19):14611. doi: 10.3390/ijms241914611.
8
AAV-based in vivo gene therapy for neurological disorders.基于腺相关病毒的神经疾病体内基因治疗。
Nat Rev Drug Discov. 2023 Oct;22(10):789-806. doi: 10.1038/s41573-023-00766-7. Epub 2023 Sep 1.
9
Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions.医疗补助计划对获批基因和细胞疗法的覆盖实践：现存障碍与政策解决方案建议
Mol Ther Methods Clin Dev. 2023 May 16;29:513-521. doi: 10.1016/j.omtm.2023.05.015. eCollection 2023 Jun 8.
10
Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems.工程化 AAV 用于非侵入性基因递送至啮齿动物和非人灵长类动物神经系统。
Neuron. 2022 Jul 20;110(14):2242-2257.e6. doi: 10.1016/j.neuron.2022.05.003. Epub 2022 May 27.
本文引用的文献
1
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery.通过系统性 scAAV9-hSGSH 基因传递，在 MPS IIIA 小鼠疾病晚期对神经和躯体障碍进行功能矫正。
Mol Ther Methods Clin Dev. 2016 Jun 8;3:16036. doi: 10.1038/mtm.2016.36. eCollection 2016.
2
Methods for gene transfer to the central nervous system.基因转移至中枢神经系统的方法。
Adv Genet. 2014;87:125-97. doi: 10.1016/B978-0-12-800149-3.00003-2.
3
Clinical applications involving CNS gene transfer.涉及中枢神经系统基因转移的临床应用。
Adv Genet. 2014;87:71-124. doi: 10.1016/B978-0-12-800149-3.00002-0.
4
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy.通过脑脊液基因疗法对黏多糖贮积症IIIA进行全身矫正。
J Clin Invest. 2013 Aug 1;123(8):3254-3271. doi: 10.1172/JCI66778. Epub 2013 Jul 1.
5
A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.在 P20 时，单次静脉注射 rAAV 即可在 Canavan 小鼠中实现有效且持续的中枢神经系统基因治疗。
Mol Ther. 2013 Dec;21(12):2136-47. doi: 10.1038/mt.2013.138. Epub 2013 Jul 2.
6
Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer.通过系统性 AAV9 基因转移纠正 MPSIIIA 小鼠中枢神经系统和外周组织中糖胺聚糖的病理性积累。
Hum Gene Ther. 2012 Dec;23(12):1237-46. doi: 10.1089/hum.2012.029. Epub 2012 Oct 17.
7
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response.黏多糖贮积症 IIIB 是一种溶酶体贮积病，可引发致病性中枢神经系统自身免疫反应。
J Neuroinflammation. 2010 Jul 16;7:39. doi: 10.1186/1742-2094-7-39.
8
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.通过在出生后早期递送 SMN 挽救小鼠模型中的脊髓性肌萎缩表型。
Nat Biotechnol. 2010 Mar;28(3):271-4. doi: 10.1038/nbt.1610. Epub 2010 Feb 28.
9
Newborn screening for Krabbe disease: the New York State model.克拉贝病的新生儿筛查：纽约州模式。
Pediatr Neurol. 2009 Apr;40(4):245-52; discussion 253-5. doi: 10.1016/j.pediatrneurol.2008.11.010.
10
Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis.新生儿中枢神经系统基因转移对晚期婴儿神经元蜡样脂褐质沉积症的生存优势。
Exp Neurol. 2008 Sep;213(1):18-27. doi: 10.1016/j.expneurol.2008.04.022. Epub 2008 Apr 30.
Zotero 插件